Updated on : 29-03-2026
| This draft Commission Implementing Decision does not approve poly(dimethyloctadecyl[3-(trihydroxysilyl)propyl]ammonium chloride) generated from dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride as an existing active substance for use in biocidal products of product types 2, 7 and 9.This active substance cannot be approved due to major data gaps, including validated analytical methods and physico-chemical properties of the substance. Since reliable analytical methods could not be established, it was not possible to conclude on the acceptability of the risks concerning human health and the environment. Due to the same reasons, it was not possible to conclude whether the active substance is carcinogenic, mutagenic or toxic for reproduction. Finally, sufficient efficacy was not demonstrated for any of the assessed product-types.As a consequence, articles treated with or incorporating this active substance may not be placed on the market in the Union 180 days after a decision on the non-approval. |